Federal Register / Vol. 72, No. 149 / Friday, August 3, 2007 / Notices 43287 

0–PCT–02), claiming priority to 24 Feb 

2006, entitled ‘‘Immunogenic Peptides 

and Methods of Use.’’

Licensing Contact: Jesse S. Kindra, 

J.D.; 301/435–5559; 

kindraj@mail.nih.gov; or Michelle A. 

Booden, PhD.; 301/451–7337; 

boodenm@mail.nih.gov. 

Dated: July 26, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–15056 Filed 8–2–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

ODS Analytical Methods and 

Reference Materials Program 

Stakeholders’ Meeting Notice 

Notice is hereby given of the National 

Institutes of Health (NIH) Office of 

Dietary Supplements (ODS) Analytical 

Methods and Reference Materials 

Program Stakeholders’ Meeting to be 

held Monday, September 10, 2007, in 

the Lister Hill Auditorium on the NIH 

Campus in Bethesda, Maryland 20892. 

The meeting will begin at 9 a.m. and 

will be open to the public. 

In fiscal year (FY) 2002, Congress 

addressed the need for support of 

analytical methods and reference 

materials development related to dietary 

supplements. The congressional 

appropriations language supported an 

increased ODS budget for several topics, 

including analytical methods and 

reference materials. The Senate 

language called for ‘‘ODS to allocate 

sufficient funds to speed up an ongoing 

collaborative effort to develop and 

disseminate validated analytical 

methods and reference materials for the 

most commonly used botanicals and 

other dietary supplements.’’

On February 8, 2002, ODS held a 

public meeting to solicit comments to 

assist ODS in designing an overall 

strategy for implementing the 

congressional mandate to foster 

development and validation of 

analytical methods and reference 

materials for dietary supplements. 

In FY 2004 and 2005, Congress again 

used similar language supporting the 

Analytical Methods and Reference 

Materials (AMRM) program in the ODS 

appropriations. 

The purpose of the proposed meeting 

on September 10, 2007, is to state the 

progress that has been made by the 

AMRM program since its inception five 

years ago and to receive comments on 

directions for the next five years. The 

meeting is intended to seek stakeholder 

comments that will assist us with the 

continued implementation of an overall 

strategy for research, development, 

validation, and dissemination of 

analytical methods and standard 

reference materials for dietary 

supplement ingredients. The sponsor of 

this meeting is the NIH Office of Dietary 

Supplements. 

Registration: Ms. Channet Williams of 

the American Institutes of Research will 

be coordinating the registration for this 

meeting. To register, please forward 

your name and complete mailing 

address, including phone number, via email to cwilliams@air.org. If you don’t 

have access to e-mail, please call Ms. 

Williams at 301–592–2130. American 

Institutes for Research’s mailing address 

is 10720 Columbia Pike, Silver Spring, 

Maryland 20901. Registration 

information, as well as background 

information about the AMRM program, 

is available at http:// 

www.ods.od.nih.gov. 

If you wish to make an oral 

presentation during the meeting, you 

must indicate this when you register 

and submit the following information: 

(1) A brief written statement of the 

general nature of the statement that you 

wish to present, (2) the names and 

addresses of the person(s) who will give 

the presentation, and (3) the 

approximate length of time that you are 

requesting for your presentation. 

Depending on the number of people 

who register to make presentations, we 

may have to limit the time allotted for 

each presentation. 

Please Note: The NIH has instituted new 

security measures to ensure the safety of NIH 

employees and property. All visitors must be 

prepared to show a photo ID upon request. 

Visitors may be required to pass through a 

metal detector and have bags, backpacks, or 

purses inspected or x-rayed as they enter NIH 

buildings. For more information about the 

new security measures at NIH, please visit 

the Web site at http://www.nih.gov/about/ 

visitorsecurity.htm. 

Dated: July 25, 2007. 

Elias A. Zerhouni, 

Director, National Institutes of Health. 

[FR Doc. E7–15048 Filed 8–2–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory General Medical 

Sciences Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

General Medical Sciences Council, 

Date: September 10–11, 2007. 

Closed: September 10, 2007, 8:30 a.m. to 5 

p.m. 

Agenda: To Review and Evaluate Grant 

Applications. 

Place: National Institutes of Health, 

Natcher Building, Conference Rooms E1 & 

E2, 9000 Rockville Pike, Bethesda, MD 

20892. 

Open: September 11, 2007, 8:30 a.m. to 

adjournment. 

Agenda: For the Discussion of Program 

Policies and Issues, Opening Remarks, Report 

of the Director, NIGMS, and Other Business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, Conference Rooms E1 & 

E2, 9000 Rockville Pike, Bethesda, MD 

20892. 

Contact Person: Ann A. Hagan, PhD, 

Associate Director for Extramural Activities, 

NIGMS, NIH, DHHS, 45 Center Drive, Room 

2AN24H, MSC6200, Bethesda, MD 20892–

6200, (301) 594–4499. 

hagana@nigms.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

mstockstill on PROD1PC66 with NOTICES

43288 Federal Register / Vol. 72, No. 149 / Friday, August 3, 2007 / Notices 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s Center’s home page: http:// 

www.nigms.nih.gov/about/ 

advisory_council.html, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS). 

Dated: July 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–3775 Filed 8–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Mental Health 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Mental Health Council. 

Date: September 20–21, 2007. 

Closed: September 20, 2007, 10:30 a.m. to 

3:45 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C/D/E, 

Rockville, MD 20852. 

Open: September 20, 2007, 4 p.m. to 5 p.m. 

Agenda: Discussion on NIMH program and 

policy issues. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C/D/E, 

Rockville, MD 20852. 

Open: September 21, 2007, 8:30 a.m. to 

12:30 p.m. 

Agenda: Presentation of NIMH Director’s 

Report and discussion on NIMH program and 

policy issues. 

Place: National Institutes of Health, 

Building 31C, 31 Center Drive, 6th Floor, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Jane A. Steinberg, PhD, 

Director, Division of Extramural Activities, 

National Institute of Mental Health, NIH, 

Neuroscience Center, 6001 Executive Blvd., 

Room 6154, MSC 9609, Bethesda, MD 20892–

9609, 301–443–5047. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page http:// 

www.nimh.nih.gov/council/advis.cfm, where 

an agenda and any additional information 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: July 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–3777 Filed 8–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, 

Conference Grant Review. 

Date: August 9, 2007. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Bethesda, MD 20852, 

(Telephone Conference Call). 

Contact Person: Melissa Stick, PhD, MPH 

Chief, Scientific Review Branch, Division of 

Extramural Activities NIDCD/NIH, 6120 

Executive Blvd., Bethesda, MD 20892, 301–

496–8683. 

This notice is being published less than 15 

days prior to the meeting to the time 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deadness and Communicative 

Disorders, National Institutes of Health, 

HHS). 

Dated: July 27, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–3778 Filed 8–2–07; 8:45 am] 

BILLING CODE 4140–01–M 

mstockstill on PROD1PC66 with NOTICES